AstraZeneca_NN
Annual_JJ
Report_NN
and_PHC
AstraZeneca_NN
Code_NN
of_PIN
Conduct_NN
138_CD
Form_NN
20-F_JJ
Information_NOMZ
2003_CD
AstraZeneca_NN
Code_NN
of_PIN
Conduct_NN
Introduction_NOMZ
situation_NOMZ
that_TSUB
may_POMD
confront_VB
employees_NN
in_PIN
No_SYNE
employee_NN
should_NEMD
seek_VB
or_CC
accept_VB [PRIV]
a_DT
gift_NN
,_,
We_FPP1
are_VPRT [PASS]
committed_VBN
to_TO
dealing_VBG
with_PIN
all_QUAN
our_FPP1
markets_NN
around_PLACE
the_DT
world_NN
._.
In_PIN
appropriate_JJ
entertainment_NOMZ
or_CC
personal_JJ
favor_NN
which_WDT [WHSUB]
stakeholders_VPRT
with_PIN
the_DT
highest_JJ
ethical_JJ
cases_NN
,_,
guidance_NN
on_PIN
the_DT
application_NOMZ
of_PIN
the_DT
might_POMD [SPAU]
reasonably_RB
be_VB [PASS]
believed_VBN [PRIV]
to_TO
have_VB
any_QUAN
standards_NN
,_,
integrity_NOMZ
and_CC
as_IN
responsible_JJ
Code_NN
to_PIN
particular_JJ
situations_NOMZ
should_NEMD
be_VB
influence_NN
on_PIN
business_NOMZ
transactions_NOMZ
._.
The_DT
trust_NN
and_PHC
confidence_NN
sought_VBD
from_PIN
management_NOMZ
._.
In_CONJ
addition_NULL
,_,
Legal_NN
of_PIN
entertainment_NOMZ
should_NEMD
not_XX0
be_VB [PASS]
accepted_VBN [PRIV]
of_PIN
all_QUAN
our_FPP1
stakeholders_NN
,_,
together_RB
with_PIN
our_FPP1
Department_NOMZ
and_PHC
Group_NN
Internal_NN
Audit_NN
are_VPRT
unless_COND
the_DT
offer_NN
is_VPRT [BEMA]
within_PIN
the_DT
bounds_NN
of_PIN
reputation_NOMZ
,_,
are_VPRT [BEMA]
among_PIN
the_DT
most_EMPH
valuable_JJ
available_JJ
on_PIN
a_DT
confidential_JJ
basis_NN
as_IN
accepted_VBN [PRIV]
business_NOMZ
hospitality_NOMZ
._.
Gifts_NN
which_WDT [WHOBJ]
assets_NN
of_PIN
the_DT
Group_NN
._.
Along_IN
with_PIN
our_FPP1
independent_JJ
sources_NN
of_PIN
advice_NN
._.
do_VB
not_XX0
meet_VB
the_DT
above_PLACE
criteria_NN
should_NEMD
be_VB
commitment_NOMZ
to_PIN
competitiveness_NOMZ
and_CC
reported_VBD [PUBV]
to_PIN
management_NOMZ
who_WP [WHSUB]
shall_PRMD
performance_NN
,_,
we_FPP1
will_PRMD
continue_VB
to_TO
be_VB [BYPA]
led_VBN
by_PIN
It_PIT
is_VPRT [BEMA]
the_DT
responsibility_NOMZ
of_PIN
each_QUAN
employee_NN
to_TO
determine_VB [SUAV] [PRIV]
how_RB [WHCL]
they_TPP3
shall_PRMD
be_VB [PASS]
dealt_VBN
with_PIN [STPR]
._.
our_FPP1
values_NN
to_TO
achieve_VB
sustainable_JJ
success_NN
._.
report_NN
promptly_RB
any_QUAN
violations_NOMZ
of_PIN
the_DT
Code_NN
of_PIN
Conduct_NN
of_PIN
which_WDT [PIRE]
they_TPP3
become_VPRT
aware_JJ
._.
AstraZeneca_NN
funds_NN
will_PRMD
not_XX0
be_VB [PASS]
used_VBN
in_PIN
Every_QUAN
AstraZeneca_NN
employee_NN
is_VPRT [PASS]
required_VBN [SUAV]
to_PIN
Details_NN
of_PIN
the_DT
procedures_NN
for_PIN
raising_VBG
integrity_NOMZ
payments_NOMZ
,_,
direct_JJ
or_CC
indirect_JJ
,_,
to_PIN
government_NOMZ
make_VB
a_DT
personal_JJ
commitment_NOMZ
to_TO
follow_VB
the_DT
concerns_NN
and_CC
relevant_JJ
contact_NN
details_NN
are_VPRT
officials_NN
,_,
people_NN
participating_VBG [WZPRES]
in_PIN
government_NOMZ
Companys_NN
Code_NN
of_PIN
Conduct_NN
,_,
as_RB
well_RB
as_IN
the_DT
given_VBN
at_PIN
the_DT
end_NN
of_PIN
this_DEMO
document_NOMZ
._.
bodies_NN
,_,
employees_NN
of_PIN
state_NN
organizations_NOMZ
or_CC
detailed_JJ
standards_NN
issued_VBN [WZPAST]
in_PIN
support_NN
of_PIN
it_PIT
,_,
AstraZeneca_NN
assures_VPRT
individual_JJ
employees_NN
representatives_NN
of_PIN
political_JJ
parties_NN
,_,
for_PIN
and_CC
uphold_VB
our_FPP1
commitment_NOMZ
to_PIN
our_FPP1
values_NN
,_,
who_WP
raise_VPRT
issues_NN
that_TOBJ
they_TPP3
will_PRMD
be_VB [PASS]
protected_VBN
unlawful_JJ
or_CC
improper_JJ
purposes_NN
._.
from_PIN
any_QUAN
adverse_JJ
impact_NN
on_PIN
their_TPP3
employment_NOMZ
as_CONJ
a_NULL
result_NULL
._.
AstraZeneca_NN
Equal_NN
opportunities_NOMZ
We_FPP1
are_VPRT [BEMA]
all_QUAN
privileged_JJ
to_TO
work_VB
for_PIN
one_CD
of_PIN
the_DT
actively_RB
encourages_VPRT
employees_NN
to_TO
raise_VB
All_QUAN
employees_NN
shall_PRMD
be_VB [PASS]
treated_VBN
with_PIN
equal_JJ
best_JJ
companies_NN
in_PIN
the_DT
world_NN
and_CC
to_TO
ensure_VB [SUAV] [PRIV]
issues_NN
of_PIN
concern_NN
._.
respect_NN
and_PHC
dignity_NOMZ
and_CC
shall_PRMD
be_VB [PASS]
provided_VBN
we_FPP1
leave_VPRT
a_DT
lasting_JJ
legacy_NN
that_TOBJ
we_FPP1
can_POMD
be_VB [BEMA]
with_PIN
equality_NOMZ
of_PIN
opportunity_NOMZ
to_TO
develop_VB
proud_JJ
of_PIN [STPR]
._.
Nothing_INPR
not_XX0
the_DT
need_NN
to_TO
meet_VB
Standards_NN
of_PIN
Conduct_NN
themselves_TPP3
and_CC
their_TPP3
careers_NN
._.
targets_NN
,_,
or_CC
direct_JJ
orders_NN
from_PIN
a_DT
superior_JJ
Business_NOMZ
practices_NN
should_NEMD [SPAU]
ever_RB
compromise_VB
our_FPP1
commitment_NOMZ
AstraZeneca_NN
Companies_NN
,_,
and_ANDC
their_TPP3
AstraZeneca_NN
is_VPRT
striving_VBG
to_TO
achieve_VB
diversity_NOMZ
to_PIN
honesty_NN
and_PHC
integrity_NOMZ
._.
employees_NN
,_,
must_NEMD
comply_VB
with_PIN
the_DT
laws_NN
of_PIN
at_PIN
all_QUAN
levels_NN
of_PIN
the_DT
organization_NOMZ
and_CC
values_VPRT
the_DT
all_QUAN
countries_NN
in_PIN
which_WDT [PIRE]
they_TPP3
operate_VPRT
,_,
with_PIN
individuality_NOMZ
,_,
diversity_NOMZ
and_CC
creative_JJ
potential_JJ
Sir_NN
Tom_NN
McKillop_NN
appropriate_JJ
international_JJ
and_PHC
national_JJ
that_THAC
every_QUAN
employee_NN
brings_VPRT
to_PIN
its_PIT
business_NOMZ
Chief_NN
Executive_NN
industry_NN
codes_NN
of_PIN
practice_NN
and_CC
with_PIN
the_DT
and_CC
supports_VPRT
the_DT
continuous_JJ
development_NOMZ
high_JJ
ethical_JJ
standards_NN
specified_VBN [WZPAST]
by_PIN
of_PIN
their_TPP3
skills_NN
and_PHC
abilities_NOMZ
._.
Policy_NN
Judgements_NOMZ
about_IN
people_NN
for_PIN
the_DT
purpose_NN
of_PIN
AstraZeneca_NN
requires_VPRT [SUAV]
its_PIT
companies_NN
,_,
and_ANDC
It_PIT
is_VPRT [BEMA]
the_DT
responsibility_NOMZ
of_PIN
all_QUAN
employees_NN
to_PIN
recruitment_NOMZ
,_,
development_NOMZ
or_CC
promotion_NOMZ
shall_PRMD
their_TPP3
employees_NN
,_,
to_TO
observe_VB [PRIV]
the_DT
highest_JJ
ensure_VB [SUAV] [PRIV]
,_,
by_PIN
taking_VBG
advice_NN
where_RB
appropriate_JJ
,_,
be_VB [PASS]
made_VBN
solely_RB
on_PIN
the_DT
basis_NN
of_PIN
a_DT
persons_NN
standards_NN
of_PIN
integrity_NOMZ
and_PHC
honesty_NN
and_PHC
act_NN
that_TOBJ
they_TPP3
are_VPRT [BEMA]
fully_AMP
aware_PRED
of_PIN
all_QUAN
relevant_JJ
laws_NN
,_,
ability_NOMZ
and_PHC
potential_NN
in_PIN
relation_NOMZ
to_PIN
the_DT
needs_NN
of_PIN
with_PIN
due_JJ
skill_NN
,_,
care_NN
,_,
diligence_NN
and_PHC
fairness_NOMZ
in_PIN
regulations_NOMZ
,_,
practices_NN
and_PHC
codes_NN
of_PIN
practice_NN
,_,
the_DT
job_NN
and_CC
shall_PRMD [SPAU]
only_DWNT
take_VB
account_NN
of_PIN
matters_NN
the_DT
conduct_NN
of_PIN
business_NOMZ
._.
To_PIN
this_DEMO
end_NN
all_QUAN
particularly_RB
as_IN
they_TPP3
relate_VPRT
to_PIN
their_TPP3
job_NN
._.
relevant_JJ
to_PIN
the_DT
performance_NN
of_PIN
that_DEMO
job_NN
._.
AstraZeneca_NN
Companies_NN
,_,
and_ANDC
their_TPP3
Overall_JJ
,_,
success_NN
and_PHC
advancement_NOMZ
within_PIN
employees_NN
,_,
are_VPRT [PASS]
required_VBN [SUAV]
to_TO
comply_VB
with_PIN
the_DT
Employees_NN
should_NEMD
ensure_VB [SUAV] [PRIV] [THATD]
that_DEMP
,_,
within_PIN
their_TPP3
AstraZeneca_NN
shall_PRMD
depend_VB
solely_RB
on_PIN
personal_JJ
laws_NN
of_PIN
all_QUAN
countries_NN
in_PIN
which_WDT [PIRE]
they_TPP3
operate_VPRT
sphere_NN
of_PIN
business_NOMZ
activity_NOMZ
,_,
AstraZeneca_NN
ability_NOMZ
,_,
behavior_NN
and_PHC
work_NN
performance_NN
._.
and_ANDC
with_PIN
the_DT
high_JJ
ethical_JJ
standards_NN
detailed_VBN
Companies_NN
carry_VPRT
out_PIN
their_TPP3
contractual_JJ
by_PIN
AstraZeneca_NN
in_PIN
support_NN
of_PIN
this_DEMO
policy_NN
._.
obligations_NOMZ
in_PIN
a_DT
proper_JJ
and_PHC
timely_JJ
manner_NN
In_PIN
some_QUAN
countries_NN
these_DEMO
principles_NN
may_POMD
be_VB
and_PHC
are_VPRT [BEMA]
not_XX0
in_PIN
breach_NN
of_PIN
contract_NN
._.
modified_VBN [PASTP]
by_PIN
national_JJ
legal_JJ
requirements_NOMZ
for_PIN
Compliance_NN
affirmative_JJ
action_NOMZ
._.
It_PIT
is_VPRT [BEMA]
the_DT
responsibility_NOMZ
of_PIN
management_NOMZ
to_PIN
Business_NOMZ
practice_NN
,_,
and_ANDC
what_WP
amounts_VPRT
to_TO
ensure_VB [SUAV] [PRIV]
that_THVC
the_DT
AstraZeneca_NN
Code_NN
of_PIN
improper_JJ
conduct_NN
,_,
varies_VPRT
from_PIN
country_NN
to_PIN
Personal_NN
harassment_NOMZ
Conduct_NN
and_PHC
standards_NN
are_VPRT [PASS]
communicated_VBN
,_,
country_NN
and_CC
from_PIN
industry_NN
to_PIN
industry_NN
._.
All_QUAN
Personal_JJ
harassment_NOMZ
,_,
such_JJ
as_IN
verbal_JJ
understood_VBN [PRIV]
and_PHC
acted_VBN
upon_PIN [STPR]
._.
They_TPP3
are_VPRT
employees_NN
will_PRMD
comply_VB
with_PIN
a_DT
the_DT
high_JJ
ethical_JJ
abuse_NN
or_CC
sexual_JJ
harassment_NOMZ
,_,
of_PIN
any_QUAN
required_VBN [SUAV]
to_TO [SPIN]
positively_RB
promote_VB
them_TPP3
by_PIN
standards_NN
specified_VBN [WZPAST]
by_PIN
AstraZeneca_NN
b_NN
any_QUAN
employee_NN
of_PIN
AstraZeneca_NN
,_,
its_PIT
suppliers_NN
personal_JJ
example_NN
and_CC
are_VPRT [PASS]
not_XX0
entitled_VBN
to_TO
permit_VB
published_VBN
overall_JJ
AstraZeneca_NN
Code_NN
relating_VBG [WZPRES]
or_CC
customers_NN
is_VPRT [BEMA]
unacceptable_PRED
in_PIN
any_QUAN
form_NN
any_QUAN
exceptions_NOMZ
to_PIN
the_DT
required_VBN [SUAV]
behavior_NN
._.
to_PIN
business_NOMZ
practices_NN
and_PHC
c_NN
any_QUAN
international_JJ
whatsoever_RB
._.
and_ANDC
national_JJ
codes_NN
of_PIN
practice_NN
applicable_JJ
to_PIN
All_QUAN
employees_NN
should_NEMD
familiarise_VB
themselves_TPP3
the_DT
conduct_NN
of_PIN
business_NOMZ
in_PIN
each_QUAN
environment_NOMZ
._.
Any_QUAN
person_NN
who_WP [WHSUB]
believes_VPRT [PRIV] [THATD]
they_TPP3
have_VPRT [PEAS]
been_VBN [BEMA]
with_PIN
the_DT
Code_NN
of_PIN
Conduct_NN
and_CC
must_NEMD
comply_VB
personally_RB
harassed_VBN
should_NEMD
report_VB [PUBV]
the_DT
with_PIN
it_PIT
._.
Failure_NN
to_TO
act_VB
in_PIN
compliance_NN
with_PIN
the_DT
Gifts_NN
,_,
entertainment_NOMZ
and_CC
personal_JJ
favors_NN
incident_NN
and_PHC
circumstances_NN
to_PIN
their_TPP3
Code_NN
will_PRMD
result_VB
in_PIN
appropriate_JJ
disciplinary_JJ
may_POMD [SPAU]
only_DWNT
be_VB [PASS]
offered_VBN
to_PIN
a_DT
third_JJ
party_NN
if_COND
modest_JJ
immediate_JJ
manager_NN
or_CC
HR_NN
manager_NN
or_CC
other_JJ
action_NOMZ
against_PIN
both_DT
the_DT
employee_NN
committing_VBG [WZPRES]
in_PIN
value_NN
and_ANDC
if_COND
they_TPP3
are_VPRT [BEMA]
consistent_PRED
with_PIN
senior_JJ
manager_NN
who_WP [WHSUB]
will_PRMD
arrange_VB [SUAV]
for_PIN
it_PIT
to_TO
be_VB [BEMA]
the_DT
breach_NN
and_PHC
others_NN
who_WP [WHSUB]
condone_VPRT
it_PIT
._.
No_SYNE
gifts_NN
,_,
investigated_VBD
impartially_RB
and_PHC
confidentially_RB
._.
entertainment_NOMZ
or_CC
personal_JJ
favor_NN
may_POMD
be_VB
AstraZeneca_NN
is_VPRT [BEMA]
fully_AMP
supportive_PRED
of_PIN
the_DT
The_DT
Standards_NN
set_VBD
out_PIN
in_PIN
the_DT
Code_NN
are_VPRT [PASS]
offered_VBN
in_PIN
contravention_NOMZ
of_PIN
any_QUAN
applicable_JJ
law_NN
principles_NN
set_VBN [WZPAST]
forth_RB
in_PIN
the_DT
UN_NN
Declaration_NOMZ
of_PIN
general_JJ
and_CC
do_VB
not_XX0
address_VB
each_QUAN
and_CC
every_QUAN
or_CC
code_NN
of_PIN
practice_NN
._.
These_DEMP
include_VPRT
freedom_NN
from_PIN
AstraZeneca_NN
Annual_JJ
Report_NN
and_PHC
AstraZeneca_NN
Code_NN
of_PIN
Conduct_NN
Form_NN
20-F_NN
Information_NOMZ
2003_CD
139_CD
torture_VB
and_CC
arbitrary_JJ
arrest_NN
,_,
the_DT
right_NN
to_PIN
a_DT
fair_JJ
These_DEMO
examples_NN
do_VPRT
not_XX0
extend_VB
to_PIN
normal_JJ
Policies_NN
,_,
delegated_VBN
authorities_NOMZ
and_PHC
trial_NN
and_PHC
equality_NOMZ
before_IN
the_DT
law_NN
._.
and_ANDC
proper_JJ
financial_JJ
investments_NOMZ
in_PIN
publicly_RB
reserved_VBN
powers_NN
quoted_VBN
companies_NN
._.
AstraZeneca_NN
employees_NN
are_VPRT [PASS]
expected_VBN [PRIV]
to_PIN
Political_JJ
contributions_NOMZ
make_VPRT
themselves_TPP3
aware_JJ
of_PIN
and_CC
comply_VB
Any_QUAN
political_JJ
contributions_NOMZ
by_PIN
AstraZeneca_NN
Insider_NN
information_NOMZ
with_PIN
the_DT
letter_NN
and_PHC
spirit_NN
of_PIN
all_QUAN
AstraZeneca_NN
Companies_NN
must_NEMD
be_VB [BEMA]
lawful_PRED
and_CC
approved_VBD
Employees_NN
must_NEMD
not_XX0
use_VB
confidential_JJ
policies_NN
and_CC
with_PIN
the_DT
reserved_VBN
powers_NN
and_CC
under_IN
procedures_NN
laid_VBN
down_RP
by_PIN
the_DT
board_NN
or_CC
information_NOMZ
obtained_VBN [WZPAST]
through_PIN
their_TPP3
delegated_JJ
authorities_NOMZ
established_VBN [PRIV] [WZPAST]
by_PIN
the_DT
governing_VBG
body_NN
of_PIN
the_DT
company_NN
concerned_VBN
._.
Copies_NN
of_PIN
these_DEMP
are_VPRT [BEMA]
available_PRED
on_PIN
the_DT
Companys_NN
intranet_NN
Approval_NN
should_NEMD
not_XX0
be_VB [PASS]
given_VBN
to_PIN
any_QUAN
political_JJ
It_PIT
is_VPRT
AstraZeneca_NN
policy_NN
,_,
and_ANDC
in_PIN
certain_JJ
site_NN
s._NN
contributions_NOMZ
by_PIN
AstraZeneca_NN
Companies_NN
countries_NN
a_DT
legal_JJ
requirement_NOMZ
carrying_VBG [WZPRES]
which_WDT
,_,
by_PIN
their_TPP3
scale_NN
or_CC
affiliation_NOMZ
,_,
might_POMD
be_VB [BEMA]
criminal_JJ
sanctions_NOMZ
,_,
that_THVC
employees_NN
in_PIN
The_DT
freedoms_NN
which_WDT [WHOBJ]
individuals_NN
have_VPRT
to_TO
carry_VB
seen_VBN [PRIV]
as_IN
excessive_JJ
or_CC
inappropriate_JJ
._.
possession_NN
of_PIN
confidential_JJ
price_NN
sensitive_JJ
out_PIN
their_TPP3
jobs_NN
must_NEMD
be_VB [PASS]
exercised_VBN
within_PIN
both_DT
AstraZenecas_NN
accounting_GER
procedures_NN
information_NOMZ
in_PIN
relation_NOMZ
to_PIN
securities_NOMZ
do_VPRT
not_XX0
the_DT
letter_NN
and_PHC
spirit_NN
of_PIN
AstraZeneca_NN
policies_NN
require_VPRT [SUAV]
any_QUAN
political_JJ
contribution_NOMZ
to_TO
be_VB
make_VB
use_NN
of_PIN
such_JJ
information_NOMZ
to_TO
deal_VB
in_PIN
and_CC
procedures_NN
,_,
reserved_VBN
powers_NN
and_CC
reported_VBD [PUBV]
to_PIN
AstraZeneca_NN
headquarters_NN
as_IN
securities_NOMZ
of_PIN
AstraZeneca_NN
or_CC
provide_VB
such_JJ
delegated_JJ
authorities_NOMZ
._.
These_DEMP
are_VPRT [PASS]
designed_VBN
to_PIN
part_NN
of_PIN
the_DT
annual_JJ
consolidation_NOMZ
of_PIN
results_NN
._.
information_NOMZ
to_PIN
third_JJ
parties_NN
for_PIN
that_DEMO
purpose_NN
._.
empower_VB
people_NN
to_TO
carry_VB
out_PIN
their_TPP3
The_DT
same_JJ
considerations_NOMZ
apply_VPRT
in_PIN
relation_NOMZ
to_PIN
responsibilities_NOMZ
within_PIN
a_DT
necessary_JJ
framework_NN
Conflicts_NN
of_PIN
interest_NN
confidential_JJ
price_NN
sensitive_JJ
information_NOMZ
of_PIN
corporate_JJ
control_NN
and_CC
legal_JJ
responsibility_NOMZ
Employees_NN
dealing_VBG [WZPRES]
with_PIN
AstraZenecas_NN
relating_VBG [WZPRES]
to_PIN
other_JJ
companies_NN
and_CC
dealing_VBG
in_PIN
but_CC
are_VPRT
not_XX0
so_EMPH
voluminous_PRED
as_IN
to_TO
prescribe_VB
business_NOMZ
must_NEMD
act_VB
in_PIN
the_DT
best_JJ
interests_NN
of_PIN
their_TPP3
securities_NOMZ
._.
appropriate_JJ
action_NOMZ
in_PIN
every_QUAN
circumstance_NN
._.
AstraZeneca_NN
and_CC
must_NEMD
disregard_VB
any_QUAN
personal_JJ
preference_NN
or_CC
advantage_NN
._.
Property_NN
and_PHC
resources_NN
Records_NN
,_,
disclosures_NN
and_PHC
AstraZeneca_NN
resources_NN
should_NEMD
be_VB [PASS]
kept_VBN
communications_NOMZ
Employees_NN
should_NEMD
avoid_VB
entering_VBG
into_PIN
securely_RB
and_CC
should_NEMD [SPAU]
only_DWNT
be_VB [PASS]
used_VBN
for_PIN
the_DT
AstraZeneca_NN
PLC_NN
and_CC
all_QUAN
AstraZeneca_NN
situations_NOMZ
in_PIN
which_WDT [PIRE]
their_TPP3
personal_JJ
,_,
family_NN
or_CC
proper_JJ
advancement_NOMZ
of_PIN
its_PIT
business_NOMZ
and_PHC
Companies_NN
and_CC
their_TPP3
employees_NN
are_VPRT [BEMA]
financial_JJ
interests_NN
may_POMD
conflict_VB
with_PIN
those_DEMO
of_PIN
not_XX0
for_PIN
personal_JJ
gain_NN
._.
required_VBN [SUAV]
to_TO
keep_VB
proper_JJ
accounting_GER
and_PHC
AstraZeneca_NN
._.
Where_RB
any_QUAN
potential_JJ
conflict_NN
of_PIN
other_JJ
records_NN
which_WDT [WHSUB]
give_VPRT
a_DT
true_JJ
and_PHC
fair_JJ
interest_NN
may_POMD
arise_VB
,_,
the_DT
employee_NN
shall_PRMD
declare_VB [PUBV] [THATD]
Individuals_NN
expending_VBG [WZPRES]
AstraZeneca_NN
view_NN
of_PIN
the_DT
financial_JJ
position_NOMZ
,_,
results_NN
of_PIN
that_DEMO
interest_NN
and_CC
seek_VB
advice_NN
from_PIN
senior_JJ
resources_NN
should_NEMD
recognize_VB [PRIV]
that_THVC
they_TPP3
owe_VPRT
a_DT
operations_NOMZ
,_,
transactions_NOMZ
,_,
assets_NN
and_PHC
management_NOMZ
._.
duty_NN
of_PIN
care_NN
to_PIN
the_DT
shareholders_NN
of_PIN
liabilities_NOMZ
so_RB
as_IN
to_TO
enable_VB
the_DT
Company_NN
to_PIN
AstraZeneca_NN
,_,
who_WP
are_VPRT [BEMA]
its_PIT
ultimate_JJ
owners_NN
._.
make_VB
full_JJ
,_,
fair_JJ
,_,
accurate_JJ
,_,
timely_JJ
and_CC
Examples_NN
of_PIN
conflict_NN
to_TO
be_VB [PASS]
declared_VBN [PUBV]
and_CC
Commitments_NOMZ
and_PHC
expenditure_NN
should_NEMD
only_DWNT
understandable_JJ
disclosures_NN
in_PIN
all_QUAN
reports_NN
it_PIT
resolved_VBD [SUAV]
include_VPRT
:_:
be_VB [BEMA]
such_PRED
as_IN
could_POMD
be_VB [PASS]
justified_VBN
to_PIN
shareholders_NN
is_VPRT [PASS]
required_VBN [SUAV]
to_TO
publish_VB
,_,
file_VB
or_CC
submit_VB [PUBV]
to_PIN
if_COND
the_DT
facts_NN
were_VBD [PASS]
known_VBN [PRIV]
._.
This_DEMP
includes_VPRT
any_QUAN
shareholders_NN
and_PHC
regulators_NN
and_CC
in_PIN
all_QUAN
other_JJ
having_VBG
a_DT
family_NN
interest_NN
in_PIN
a_DT
transaction_NOMZ
expenses_NN
claimed_VBD [PUBV]
and_CC
purchases_NN
made_VBN [WZPAST]
for_PIN
communications_NOMZ
which_WDT [WHOBJ]
it_PIT
publishes_VPRT
._.
with_PIN
AstraZeneca_NN
or_CC
one_CD
of_PIN
its_PIT
which_WDT
reimbursement_NOMZ
is_VPRT [PASS]
sought_VBN
._.
subsidiaries_NN
the_DT
Company_NN
or_CC
any_QUAN
All_QUAN
accounting_GER
and_CC
other_JJ
records_NN
will_PRMD
be_VB
supplier_NN
or_CC
customer_NN
:_:
AstraZeneca_NN
resources_NN
include_VPRT
not_XX0
only_DWNT
maintained_VBD [PUBV]
in_PIN
a_DT
manner_NN
that_TSUB
describes_VPRT
and_CC
tangible_JJ
assets_NN
such_JJ
as_IN
materials_NN
,_,
equipment_NOMZ
documents_NOMZ
accurately_RB
the_DT
Companys_NN
true_JJ
hiring_NN
of_PIN
a_DT
family_NN
member_NN
in_PIN
any_QUAN
capacity_NOMZ
:_:
and_ANDC
cash_NN
,_,
but_CC
also_RB
intangible_JJ
assets_NN
such_JJ
as_IN
financial_JJ
position_NOMZ
and_PHC
results_NN
of_PIN
operations_NOMZ
computer_NN
systems_NN
,_,
trade_NN
secrets_NN
and_CC
and_CC
the_DT
true_JJ
nature_NN
of_PIN
its_PIT
business_NOMZ
having_VBG [WZPRES]
an_DT
interest_NN
,_,
directly_RB
or_CC
through_PIN
confidential_JJ
information_NOMZ
._.
Employees_NN
should_NEMD
transactions_NOMZ
,_,
assets_NN
and_PHC
liabilities_NOMZ
._.
family_NN
,_,
in_PIN
a_DT
competitor_NN
,_,
supplier_NN
or_CC
observe_VB [PRIV]
global_JJ
and_PHC
local_JJ
guidelines_NN
Accounting_GER
records_NN
will_PRMD
be_VB [PASS]
kept_VBN
in_PIN
customer_NN
of_PIN
the_DT
Company_NN
:_:
concerning_VBG [PRESP]
the_DT
classifying_VBG
and_PHC
handling_VBG
of_PIN
accordance_NN
with_PIN
AstraZeneca_NN
policies_NN
,_,
documents_NOMZ
and_CC
electronic_JJ
data_NN
._.
The_DT
storage_NN
relevant_JJ
accounting_GER
standards_NN
and_CC
having_VBG
an_DT
interest_NN
,_,
directly_RB
or_CC
through_PIN
of_PIN
personal_JJ
data_NN
in_PIN
an_DT
electronic_JJ
medium_NN
appropriate_JJ
generally_RB
accepted_VBN [PRIV]
accounting_GER
family_NN
,_,
in_PIN
an_DT
organization_NOMZ
that_TSUB
has_VPRT
,_,
or_CC
may_POMD
be_VB [BYPA]
governed_VBN
by_PIN
laws_NN
with_PIN
which_WDT [PIRE]
relevant_JJ
principles_NN
._.
seeks_VPRT
to_TO
do_VB [PROD]
business_NOMZ
with_PIN
the_DT
Company_NN
:_:
employees_NN
should_NEMD
familiarise_VB
themselves_TPP3
and_CC
comply_VB
with_PIN [STPR]
._.
Employees_NN
must_NEMD
ensure_VB [SUAV] [PRIV]
that_THVC
all_QUAN
reports_NN
acquiring_VBG [WZPRES]
an_DT
interest_NN
in_PIN
property_NN
such_JJ
as_IN
published_VBN
,_,
filed_VBN
or_CC
submitted_VBN [PUBV]
to_PIN
shareholders_NN
real_JJ
estate_NN
,_,
patent_NN
rights_NN
or_CC
securities_NOMZ
Information_NOMZ
generated_VBD
within_PIN
AstraZeneca_NN
,_,
and_ANDC
regulators_NN
and_CC
all_QUAN
other_JJ
communications_NOMZ
where_RB
the_DT
Company_NN
has_VPRT
,_,
or_CC
might_POMD
have_VB
,_,
including_VBG
research_NN
and_PHC
development_NOMZ
and_ANDC
which_WDT
are_VPRT [BYPA]
published_VBN
by_PIN
the_DT
Company_NN
are_VPRT [BEMA]
full_PRED
,_,
an_DT
interest_NN
._.
manufacturing_VBG
data_NN
,_,
costs_NN
,_,
prices_NN
,_,
sales_NN
,_,
fair_JJ
,_,
accurate_JJ
,_,
timely_JJ
and_PHC
understandable_JJ
:_:
profits_NN
,_,
markets_NN
,_,
customers_NN
and_PHC
methods_NN
of_PIN
they_TPP3
must_NEMD
not_XX0
mislead_VB
the_DT
reader_NN
in_PIN
any_QUAN
way_NN
doing_VBG [WZPRES]
business_NOMZ
,_,
is_VPRT [BEMA]
the_DT
property_NN
of_PIN
nor_SYNE
omit_VB
anything_QUPR
necessary_JJ
to_TO
make_VB
them_TPP3
AstraZeneca_NN
and_CC
must_NEMD
not_XX0
,_,
unless_COND
legally_RB
full_JJ
,_,
fair_JJ
and_PHC
accurate_JJ
._.
The_DT
Chief_NN
Executive_NN
required_VBD [SUAV]
,_,
be_VB [PASS]
disclosed_VBN [PUBV]
outside_PLACE
AstraZeneca_NN
and_CC
the_DT
Companys_NN
senior_JJ
financial_JJ
officers_NN
without_PIN
proper_JJ
authority_NOMZ
._.
have_VB
a_DT
particular_JJ
responsibility_NOMZ
in_PIN
this_DEMO
regard_NN
._.
